|
US588799A
(en)
*
|
|
1897-08-24 |
|
Mechanism |
|
US3097141A
(en)
*
|
1959-02-26 |
1963-07-09 |
Kidwell Elizabeth N Wilcox |
Immunological method
|
|
SE337223B
(enExample)
|
1967-05-23 |
1971-08-02 |
Pharmacia Ab |
|
|
US3720760A
(en)
|
1968-09-06 |
1973-03-13 |
Pharmacia Ab |
Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples
|
|
US4171299A
(en)
|
1975-04-04 |
1979-10-16 |
The Regents Of The University Of California |
Polypeptide agents for blocking the human allergic response
|
|
US4352883A
(en)
|
1979-03-28 |
1982-10-05 |
Damon Corporation |
Encapsulation of biological material
|
|
US4338297A
(en)
|
1980-02-19 |
1982-07-06 |
Michael Jacob G |
Polypeptide active pollen immunosuppressant fraction
|
|
US4469677A
(en)
|
1980-02-19 |
1984-09-04 |
Michael J Gabriel |
Polypeptide active immunosuppressant fraction
|
|
FI76888C
(fi)
|
1981-04-29 |
1988-12-12 |
Ciba Geigy Ag |
Nya medel och foerpackningar foer immunologiska analyser.
|
|
CA1338705C
(en)
*
|
1981-10-22 |
1996-11-12 |
Roy Curtiss Iii |
Vaccines obtained from antigenic gene products of recombinant genes
|
|
US4888170A
(en)
*
|
1981-10-22 |
1989-12-19 |
Research Corporation |
Vaccines obtained from antigenic gene products of recombinant genes
|
|
US4659678A
(en)
|
1982-09-29 |
1987-04-21 |
Serono Diagnostics Limited |
Immunoassay of antigens
|
|
SE8205908D0
(sv)
|
1982-10-18 |
1982-10-18 |
Pharmacia Diagnostics Ab |
Sett att bilda polymerskikt
|
|
US4849337A
(en)
|
1983-01-31 |
1989-07-18 |
Minnesota Mining And Manufacturing Company |
Assaying allergen specific IgE levels with fluorogenic enzyme labeled antibody
|
|
CA1260828A
(en)
*
|
1983-07-04 |
1989-09-26 |
Masakazu Iwai |
Therapeutic and prophylactic agent for gastrointestinal ulcers
|
|
US4816449A
(en)
|
1984-08-09 |
1989-03-28 |
Immunetech Pharmaceuticals |
Immunotherapeutic anti-inflammatory peptide agents
|
|
US4579840A
(en)
|
1983-08-12 |
1986-04-01 |
Immunetech Pharmaceuticals |
Method of blocking immune complex binding to immunoglobulin Fc receptors
|
|
US4680174A
(en)
|
1984-05-24 |
1987-07-14 |
Damon Biotech, Inc. |
Induction of immune response by immunization with encapsulated antigen-producing cells
|
|
US4696915A
(en)
|
1984-05-25 |
1987-09-29 |
Hoffmann-La Roche Inc. |
Parathymosin alpha
|
|
US5026545A
(en)
|
1984-09-17 |
1991-06-25 |
Baxter International, Inc. |
Treatment of allergy and composition therefor
|
|
US4658022A
(en)
*
|
1985-08-08 |
1987-04-14 |
Molecular Diagnostics, Inc. |
Binding of antibody reagents to denatured protein analytes
|
|
US4959314A
(en)
*
|
1984-11-09 |
1990-09-25 |
Cetus Corporation |
Cysteine-depleted muteins of biologically active proteins
|
|
US4900556A
(en)
|
1985-04-26 |
1990-02-13 |
Massachusetts Institute Of Technology |
System for delayed and pulsed release of biologically active substances
|
|
US6024983A
(en)
*
|
1986-10-24 |
2000-02-15 |
Southern Research Institute |
Composition for delivering bioactive agents for immune response and its preparation
|
|
IL86583A0
(en)
*
|
1987-06-04 |
1988-11-15 |
Molecular Eng Ass |
Vaccine containing a derivative of a microbe and method for the production thereof
|
|
US5843710A
(en)
|
1987-07-07 |
1998-12-01 |
Biotech Australia Pty. Limited And Csiro |
Vaccines against animal parasitic nematodes
|
|
US5049390A
(en)
|
1987-09-02 |
1991-09-17 |
Allergy Immuno Technologies, Inc. |
Liposome containing immunotherapy agents for treating IgE mediated allergies
|
|
US5449760A
(en)
|
1987-12-31 |
1995-09-12 |
Tanox Biosystems, Inc. |
Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
|
|
US5169933A
(en)
|
1988-08-15 |
1992-12-08 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
|
AT393137B
(de)
|
1988-10-14 |
1991-08-26 |
Biomay Biotech Prod |
Verfahren zum screenen einer expressions-cdna- klonbank zur auffindung von polynukleotiden
|
|
US5061790A
(en)
*
|
1989-07-10 |
1991-10-29 |
Molecular Diagnostics, Inc. |
Oxidative denaturation of protein analytes
|
|
JP2787162B2
(ja)
|
1989-08-24 |
1998-08-13 |
フマキラー株式会社 |
精製ダニアレルゲン
|
|
US5834246A
(en)
*
|
1989-09-18 |
1998-11-10 |
Vitec Aktiebolag |
Recombinant systems for expression of cholera B-subunit with the aid of foreign promoters and/or leader peptides
|
|
US5547669A
(en)
*
|
1989-11-03 |
1996-08-20 |
Immulogic Pharma Corp |
Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I
|
|
US5328991A
(en)
*
|
1989-11-03 |
1994-07-12 |
Immulogic Pharmaceutical Corp. |
Preparation of alkali-modified cat dander allergen (Fel d I) for immunotherapeutic purposes
|
|
US6019972A
(en)
*
|
1989-11-03 |
2000-02-01 |
Immulogic Pharmaceutical Corporation |
Peptides of human T cell reactive feline protein (TRFP)
|
|
AU650249B2
(en)
|
1989-11-03 |
1994-06-16 |
Immulogic Pharmaceutical Corporation |
A human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
|
|
US5674980A
(en)
|
1989-12-21 |
1997-10-07 |
Biogen Inc |
Fusion protein comprising tat-derived transport moiety
|
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
|
AU7259691A
(en)
|
1990-01-31 |
1991-08-21 |
Board Of Regents Of The University Of Oklahoma, The |
Assays and treatments for autoimmune diseases
|
|
US6897287B1
(en)
|
1990-01-31 |
2005-05-24 |
Oklahoma Medical Research Foundation |
Ro/SSA peptide reagents for diagnosis of autoantibodies
|
|
US5084350A
(en)
|
1990-02-16 |
1992-01-28 |
The Royal Institution For The Advance Of Learning (Mcgill University) |
Method for encapsulating biologically active material including cells
|
|
US5091318A
(en)
|
1990-04-13 |
1992-02-25 |
Abbott Laboratories |
Binding of allergens to a solid phase
|
|
US5888762A
(en)
|
1990-06-05 |
1999-03-30 |
Centre National De La Recherche Scientifique (Cnrs) |
Neurotropic growth factors comprising a homeobox peptide
|
|
WO1992002621A2
(en)
|
1990-08-08 |
1992-02-20 |
Biomay Biotechnik Produktions- Und Handelsgesellschaft M.B.H. |
Allergens of alder pollen and applications thereof
|
|
AT401180B
(de)
|
1990-08-13 |
1996-07-25 |
Biomay Biotech Prod |
Für das baumpollenallergen p14 codierende rekombinante dna-moleküle, daraus hergestellte und abgeleitete polypeptide und deren verwendung
|
|
WO1992003551A1
(en)
|
1990-08-13 |
1992-03-05 |
Biomay Biotechnik Produktions- Und Handelsgesellschaft M.B.H. |
Birch pollen allergen p14 for diagnosis and therapy of allergic diseases
|
|
JP3139777B2
(ja)
|
1990-08-27 |
2001-03-05 |
フマキラー株式会社 |
組換えダニアレルゲン
|
|
KR950008087B1
(ko)
|
1990-09-17 |
1995-07-25 |
미쓰이세끼유 가가꾸고오교오 가부시끼가이샤 |
폴리카보네이트, 그 용도, 그 제조방법 및 정제방법
|
|
US5599537A
(en)
|
1990-12-18 |
1997-02-04 |
The General Hospital Corporation |
Salmonella virulence genes
|
|
US5219990A
(en)
|
1991-01-28 |
1993-06-15 |
Biogen, Inc. |
Papillomavirus e2 trans-activation repressors
|
|
US5350835A
(en)
|
1991-11-05 |
1994-09-27 |
Board Of Regents, University Of Texas |
Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
|
|
JP3156237B2
(ja)
|
1991-12-24 |
2001-04-16 |
雪印乳業株式会社 |
抗ヒトＩｇＥ モノクローナル抗体
|
|
GB2278358B
(en)
*
|
1992-02-27 |
1995-07-26 |
Lynxvale Ltd |
Heterologous gene expression in Lactococcus,and the expression products therefrom
|
|
US5480972A
(en)
|
1992-10-30 |
1996-01-02 |
The University Of Melbourne |
Allergenic proteins from Johnson grass pollen
|
|
ES2095001T5
(es)
|
1992-12-22 |
2001-03-16 |
Univ Cincinnati |
Una composicion terapeutica administrable oralmente y su metodo de obtencion.
|
|
US5558869A
(en)
|
1992-12-30 |
1996-09-24 |
University Of Arkansas |
Major peanut allergen ara h II
|
|
US5939283A
(en)
|
1992-12-31 |
1999-08-17 |
Immulogic Pharmaceutical Corporation |
Allergenic proteins and peptides from dog dander and uses therefor
|
|
ES2114184T3
(es)
|
1993-02-12 |
1998-05-16 |
Mayo Foundation |
Composicion a base de microparticulas en fase condensada y procedimiento.
|
|
WO1994019482A1
(en)
|
1993-02-22 |
1994-09-01 |
The General Hospital Corporation |
Heterologous antigens in live cell vaccine strains
|
|
JP3451572B2
(ja)
|
1993-03-04 |
2003-09-29 |
アサヒビール株式会社 |
改変したダニ主要アレルゲン及びその製造方法
|
|
FI954269A0
(fi)
|
1993-03-12 |
1995-09-12 |
Immunologic Pharma Corp |
Raiheinäsiitepölyallergeenin T-soluepitoopit
|
|
US5710126A
(en)
|
1993-03-12 |
1998-01-20 |
Immulogic Pharmaceutical Corporation |
T cell epitopes of ryegrass pollen allergen
|
|
US6849427B1
(en)
|
1993-03-12 |
2005-02-01 |
Immulogic Pharmaceutical Corp. |
Nucleic acids encoding a house dust mite allergen, Der p VII, and uses therefor
|
|
US5830463A
(en)
*
|
1993-07-07 |
1998-11-03 |
University Technology Corporation |
Yeast-based delivery vehicles
|
|
US5500161A
(en)
|
1993-09-21 |
1996-03-19 |
Massachusetts Institute Of Technology And Virus Research Institute |
Method for making hydrophobic polymeric microparticles
|
|
JP3350794B2
(ja)
|
1993-09-29 |
2002-11-25 |
アサヒビール株式会社 |
改変したダニ主要アレルゲン
|
|
JP2828391B2
(ja)
*
|
1993-10-29 |
1998-11-25 |
東燃株式会社 |
オリゴ糖を表面に有するリポソーム
|
|
US5449669A
(en)
|
1993-11-10 |
1995-09-12 |
The United States Of America As Represented By The Department Of Health And Human Services |
IgE-binding epitopes of a major heat-stable crustacean allergen derived from shrimp
|
|
US5731157A
(en)
|
1993-12-30 |
1998-03-24 |
The Procter And Gamble Company |
Two-site allergen immunoassay
|
|
US5820862A
(en)
|
1994-04-14 |
1998-10-13 |
Immulogic Pharmaceutical Corporation |
T cell epitopes of the major allergens from dermatophagoides (house dust mite)
|
|
JPH07285875A
(ja)
|
1994-04-19 |
1995-10-31 |
Mineo Hayazaki |
ノミアレルゲンの製造方法および該方法により製造されるノミアレルゲン
|
|
US5807746A
(en)
|
1994-06-13 |
1998-09-15 |
Vanderbilt University |
Method for importing biologically active molecules into cells
|
|
SE9402089D0
(sv)
|
1994-06-14 |
1994-06-14 |
Rudolf Valenta |
Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
|
|
US6239116B1
(en)
*
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
EP0819763B1
(en)
|
1995-03-28 |
2004-11-17 |
Asahi Breweries, Ltd. |
Engineered acarid allergen and process for producing the same
|
|
US5840307A
(en)
|
1995-03-31 |
1998-11-24 |
Immulogic Pharmacuetical Corp. |
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation
|
|
US6902743B1
(en)
*
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
|
US5820880A
(en)
*
|
1995-06-07 |
1998-10-13 |
The United States Of America As Represented By The Secretary Of The Army |
Liposomal formulation
|
|
US5869040A
(en)
|
1995-06-07 |
1999-02-09 |
Biogen, Inc |
Gene therapy methods and compositions
|
|
US20030202980A1
(en)
*
|
1995-12-29 |
2003-10-30 |
Caplan Michael J. |
Methods and reagents for decreasing clinical reaction to allergy
|
|
JPH11507840A
(ja)
*
|
1995-12-29 |
1999-07-13 |
ユニバーシティ オブ アーカンソー |
ピーナッツアレルゲンおよび方法
|
|
US5955593A
(en)
|
1996-09-09 |
1999-09-21 |
Washington University |
BH3 interacting domain death agonist
|
|
SE9604815D0
(sv)
*
|
1996-12-20 |
1996-12-20 |
Pharmacia & Upjohn Ab |
A metod of diagnosis
|
|
EP0973881A2
(en)
*
|
1997-03-28 |
2000-01-26 |
Cytoclonal Pharmaceutics Inc. |
Mycobacterium recombinant vaccines
|
|
US5989814A
(en)
|
1997-04-01 |
1999-11-23 |
Reagents Of The University Of California |
Screening methods in eucaryotic cells
|
|
US6060082A
(en)
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
|
DE69738124T2
(de)
|
1997-05-08 |
2008-06-12 |
Amarnath Maitra |
Verfahren zur Herstellung von hochmonodisperser, Polymeren, hydrophiler Nanopartikel
|
|
DE19729327C1
(de)
*
|
1997-07-09 |
1998-10-29 |
Wieland Electric Gmbh |
Schutzleiterklemme
|
|
US5891432A
(en)
|
1997-07-29 |
1999-04-06 |
The Immune Response Corporation |
Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same
|
|
US6024961A
(en)
*
|
1997-11-14 |
2000-02-15 |
Washington University |
Recombinant avirulent immunogenic S typhi having rpos positive phenotype
|
|
DE69940805D1
(de)
*
|
1998-01-31 |
2009-06-10 |
Sinai School Medicine |
Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie
|
|
ES2284247T3
(es)
*
|
1998-04-03 |
2007-11-01 |
University Of Iowa Research Foundation |
Metodos y productos para estimular el sistema inmunitario usando oligonucleotidos y citoquinas inmunoterapeuticos.
|
|
US6270723B1
(en)
*
|
1998-06-15 |
2001-08-07 |
Bbi Bioseq, Inc. |
Rapid cryobaric sterilization and vaccine preparation
|
|
AU748565B2
(en)
*
|
1998-06-23 |
2002-06-06 |
Board Of Trustees Of The Leland Stanford Junior University |
Adjuvant therapy
|
|
US6004815A
(en)
*
|
1998-08-13 |
1999-12-21 |
The Regents Of The University Of California |
Bacteria expressing nonsecreted cytolysin as intracellular microbial delivery vehicles to eukaryotic cells
|
|
JP2000210050A
(ja)
*
|
1998-11-20 |
2000-08-02 |
Asama Kasei Kk |
免疫調節活性分解物およびその製造方法並びにそれを用いた食品
|
|
AU3760100A
(en)
*
|
1999-03-16 |
2000-10-04 |
Panacea Pharmaceuticals, Llc |
Immunostimulatory nucleic acids and antigens
|
|
US8246945B2
(en)
*
|
2000-04-06 |
2012-08-21 |
University Of Arkansas |
Methods and reagents for decreasing clinical reaction to allergy
|
|
ES2260078T3
(es)
*
|
2000-04-06 |
2006-11-01 |
Seer Pharmaceuticals, Llc. |
Sistema de administracion microbiana.
|
|
US20050063994A1
(en)
*
|
2000-04-06 |
2005-03-24 |
Caplan Michael J. |
Methods and reagents for decreasing clinical reaction to allergy
|
|
DE60032250T2
(de)
*
|
2000-12-28 |
2007-03-15 |
Biomay Produktions- Und Handels-Aktiengesellschaft |
Behandlung von Allergien
|
|
US7265208B2
(en)
*
|
2001-05-01 |
2007-09-04 |
The Regents Of The University Of California |
Fusion molecules and treatment of IgE-mediated allergic diseases
|
|
US20050175630A1
(en)
*
|
2003-12-23 |
2005-08-11 |
Eyal Raz |
Immunogenic compositions and methods of use thereof
|